The board of Park Medi World at its meeting held on 31 August 2026 has approved the incorporation of a wholly-owned subsidiary as a Special Purpose Vehicle for a 550-bed multi-super-speciality hospital in Prayagraj, Uttar Pradesh. According to the company's regulatory filing with the National Stock Exchange of India (NSE), the proposed entity will operate under the name and style of Park Medicity Prayagraj Limited or Park Hospital Prayagraj Limited, subject to approval by the Ministry of Corporate Affairs. The company will subscribe to ₹0.15 crore worth of equity shares with a face value of ₹10 each, totaling ₹15 lakh to establish 100% ownership in the newly approved Prayagraj SPV. The board meeting commenced at 10:00 AM and concluded at 10:55 AM, with the company demonstrating transparency by disseminating this information on its official website. As per the latest reports, the initial subscription cost of ₹0.15 crore represents a nominal amount, with further capital commitments expected as the hospital development progresses under the PPP arrangement.
The ₹200 crore Prayagraj hospital project has been awarded to Park Medi World under the Public-Private Partnership (PPP) model by the Prayagraj Municipal Corporation. This reimbursement structure provides significant government support, with the Prayagraj Municipal Corporation reimbursing ₹76.52 crore towards construction costs. This reimbursement de-risks approximately 38% of the capital outlay, with the remaining funding requirement estimated at ₹123.48 crore. The project will be constructed and operated under a 45-year lease arrangement, with completion targeted within 2 years of the appointed date. The strategic utilization of a dedicated SPV for the Prayagraj hospital is described as a highly credit-positive structural move that helps insulate the core balance sheet during the construction phase. The filing notes that no specific governmental approvals are required for the incorporation itself, though the broader PPP project remains subject to the terms set by the Prayagraj Municipal Corporation.
The hospital will be constructed on a 3.22-acre site located directly behind Arail Ghat, with an expansion option for an additional 2.47 acres from the fifth year following commercial operations. This project represents Park Medi World's expansion into the healthcare infrastructure sector through a strategic Public-Private Partnership arrangement. The company is actively executing its pipeline to expand capacity from the current 4,290 beds to 5,740 beds by March 2028, with the Prayagraj facility contributing significantly to this growth target. The Prayagraj hospital will encompass multiple medical specialisations, enhancing the healthcare infrastructure in the region and aligning with the company's vision to offer state-of-the-art medical services. The project reflects the broader structural trend in India's healthcare sector, where private sector participation through PPP models continues to expand capacity in Tier-2 cities like Prayagraj, where urban growth has increased demand for tertiary and super-speciality medical services.
The company's financial momentum has strengthened with Q1 FY27 consolidated revenue growing 19% YoY to ₹475.7 crore, while net profit rose 35% YoY to ₹88.6 crore. Total operational bed capacity reached 3,960 beds as of June 30, 2026, marking a 32% growth compared to 3,000 beds in the previous year's corresponding quarter. On August 2, 2026, Park Medi World commissioned 'The Medicity Hospital, Rudrapur' in Uttarakhand, expanding its operational presence to six states with 330 additional beds. The company's structured approach to large-scale hospital expansion positions it as a key growth player in Indian healthcare.
